Blood derivatives manufacturing · California

BD Biosciences

San Diego, CA · ~415 workers · 6 years of OSHA Injury Tracking Application data.

A
Excellent Safety Record
1.1
Avg TCR
3.3
Industry avg
0
Fatalities
Subscribe to safety-record updates (RSS)

The verdict

BD Biosciences runs at 33% of its industry's injury rate - far safer than the typical Blood derivatives manufacturing workplace, earning a grade A.

BD Biosciences: 1.1 TCR = 33% of Blood derivatives manufacturing BLS 3.3 · 6y Form 300A (see methodology below)

BD Biosciences safety composite

BD Biosciences scores strongest on total case rate (tcr) (safer than 53% of same-industry peers) and weakest on fatalities (safer than 50%), blended into one 0-100 breakdown against same-industry peers. A missing measure drops out and redistributes its weight rather than deflating the score. This is a per-dimension breakdown, distinct from the single letter grade above it (which weights TCR alone against the BLS industry benchmark).

D

52/100

Percentile-weighted across 3 of 3 measures

Total Case Rate (TCR)
D 1.09 per 100 workers

Safer than 53% of industry peers

DART rate
D 0.44 per 100 workers

Safer than 52% of industry peers

Fatalities
D 0

Safer than 50% of industry peers

Benchmarked live against every credibly-rated employer in the same NAICS industry code in the current OSHA extract (a segment must have at least 8 rated peers to benchmark). Not a legal or compliance determination; PlainSafetyScore's own weighting (TCR 40%, DART 35%, fatalities 25%).

TCR Δ

−1.0

2016→2024

BD Biosciences injury rate improved

BD Biosciences's TCR fell 1.0 from 1.7 in 2016 to 0.7 in 2024. Peak filing year was 2016 at 1.7 TCR. In 2024, DART was 0.4× this establishment's average TCR (severity share of cases).

2016=1.7 · 2017=1.6 · 2018=1.3 · 2019=1.0 · 2022=0.2 · 2024=0.7

OSHA ITA Form 300A scorecard

Establishment book 325414 · San Diego, CA AT/BELOW-IND · MID

Grade A · TCR 1.1 · 33% of ind

  • DART 0.4 DART
  • RANK #8/29
  • PHOTO Gilead Sciences Inc
  • BOOK 6y book
  • INJ 26 inj
  • SIZE ~415 FTE

Nearest TCR peer: Gilead Sciences Inc (0.0 TCR gap)

Read with this employer → · Industry book → · California employers → · Look up another →

BD Biosciences in the TCR neighbourhood

Average Total Case Rate among this establishment and nearest same-industry peers

TCR

What this shows BD Biosciences averages 1.1 TCR (33% of the Blood derivatives manufacturing BLS benchmark).

Source U.S. Department of Labor, OSHA Injury Tracking Application (Form 300A) As of 2026-08-25

BD Biosciences TCR series: 2016=1.7 · 2017=1.6 · 2018=1.3 · 2019=1 · 2022=0.2 · 2024=0.7 · BLS 3.3

Where BD Biosciences falls in its industry

234 Blood derivatives manufacturin establishments

Safer than 53% of graded establishments in this industry, whose median TCR is 1.2.

More dangerous than peersSafer than peers

Narrower to California alone (the establishments it most directly competes with for workers and contracts): ranked #8 safest of 29 Blood derivatives manufacturin employers in California.

BD Biosciences (415 employees, TCR 1.1) among 29 same-industry peers, split at the industry median of 198 employees and a TCR of 1.2 2×2 strategic matrix plotting 30 entities by Average employees (X) and Total Case Rate (Y), with a crosshair dividing the plot into four quadrants. Larger & higher-riskSmaller & higher-riskLarger & saferSmaller & safer than peers 05001,0001,5002,000 0246 Average employees Total Case Rate BD Biosciences
BD Biosciences (415 employees, TCR 1.1) among 29 same-industry peers, split at the industry median of 198 employees and a TCR of 1.2

BD Biosciences has more employees than the Blood derivatives manufacturing median and a lower injury rate than the industry's median TCR of 1.2. Workforce size and injury rate do not always move together within the same industry -- some of its smaller peers run higher rates than its larger ones, and vice versa.

Year-by-Year Safety Data

Year TCR DART Injuries Illnesses Fatalities
2024 0.7 0.4 3 0 0
2022 0.2 0.0 1 0 0
2019 1.0 0.3 4 0 0
2018 1.3 0.8 5 0 0
2017 1.6 1.3 6 0 0
2016 1.7 1.7 7 0 0

OSHA ITA peer cross-reference

Establishment peer ledger

325414 · CA · San Diego

234 Blood derivatives manufacturing employers nationwide with a credible TCR · 51,834 rated employers in California with headcount on file · 1,979 employers in San Diego, CA · 4 cross-state NAT-TCR peers · 4 cross-state NAT-SIZE peers. Closest matches by relationship code are listed below.

Rel Establishment Metric
NAICS-TCR Gilead Sciences Inc 1.1 TCR
NAICS-TCR GEHC : Logan UT, LS 1.1 TCR
NAICS-TCR Novozymes Biologicals 1.1 TCR
NAICS-TCR Newport Laboratories Diagnostics/R&D 1.1 TCR
STATE-SIZE Rio Farms 415 FTE
STATE-SIZE Vineyard Management 415 FTE
STATE-SIZE RCP-SALINAS 415 FTE
STATE-SIZE University Mechanical & Engineering Contractors 415 FTE
CITY-NEAR UC San Diego Health 9,310 FTE
CITY-NEAR General Atomics 8,108 FTE
CITY-NEAR Health Human Services Agency 6,080 FTE
CITY-NEAR National University 4,955 FTE
NAT-TCR Southern Felt Co North Augusta 1.1 TCR
NAT-TCR Palm Harbor 1.1 TCR
NAT-TCR Raymow Construction Co., Inc. 1.1 TCR
NAT-TCR Hurricane Fence Co 1.1 TCR
NAT-SIZE Par Sterile Products LLC 415 FTE
NAT-SIZE BT Beltsville 415 FTE
NAT-SIZE Hydro Yankton 415 FTE
NAT-SIZE Munster in 415 FTE

Rel codes: NAICS-TCR · STATE-SIZE · CITY-NEAR · NAT-TCR/NAT-SIZE cross-state. Read with this employer →

Data Source: OSHA Injury Tracking Application (ITA), mandatory establishment-level injury/illness reports. Grades compare employer Total Case Rate (TCR) to BLS IIF industry benchmarks. Data covers years reported by this establishment: 2024, 2022, 2019, 2018, 2017, 2016. This is publicly available government data - not a legal determination of workplace conditions.

Read our methodology - how this data is sourced, computed, and verified.

Data sourced from official public datasets. See our methodology for details.